SlideShare ist ein Scribd-Unternehmen logo
1 von 31
By:Dr.M.Usman Khalid
DPT,MS-NMPT
The nervous system is divided into two anatomical divisions:
1. The central nervous system (CNS), which is composed of the
brain and spinal cord,
2. The peripheral nervous system, which includes neurons
located outside the brain and spinal cord that is, any nerves
that enter or leave the CNS.
The peripheral nervous system is subdivided into the
1. EFFERENT DIVISION, the neurons of which carry signals
away from the brain and spinal cord to the peripheral tissues,
2. AFFERENT DIVISION, the neurons of which bring
information from the periphery to the CNS.
• The efferent portion of the peripheral nervous system
is further divided into two major functional
subdivisions, the somatic and the autonomic systems.
• The SOMATIC efferent neurons are involved in the
voluntary control of functions such as contraction of
the skeletal muscles essential for locomotion.
• On the other hand, the AUTONOMIC system
regulates the everyday requirements of vital bodily
functions without the conscious participation of the
mind.
• All neurons are distinct anatomic units, and no structural
continuity exists between most neurons.
• Communication between nerve cells and between nerve
cells and effector organs occurs through the release of
specific chemical signals, called neurotransmitters, from
the nerve terminals. This release is triggered by the arrival
of the action potential at the nerve ending, leading to
depolarization.
• The neurotransmitters rapidly diffuse across the synaptic
cleft or space (synapse) between neurons and combine
with specific receptors on the postsynaptic (target) cell.
• An important traditional classification of autonomic nerves is
based on the primary transmitter molecules—acetylcholine or
norepinephrine—released from their terminals and varicosities.
A large number of peripheral ANS fibers synthesize and release
acetylcholine; they are cholinergic fibers; that is, they work by
releasing acetylcholine.
• Acetylcholine (ACh) is the primary transmitter in all
autonomic ganglia and at the synapses between
parasympathetic postganglionic neurons and their
effector cells.
• It is the transmitter at postganglionic sympathetic
neurons to the thermoregulatory sweat glands.
• It is also the primary transmitter at the somatic (voluntary)
skeletal muscle neuromuscular junction.
• 1. Synthesis and storage—Acetylcholine is synthesized
in the nerve terminal by the enzyme choline
acetyltransferase (ChAT) from acetyl-CoA (produced in
mitochondria) and choline (transported across the cell
membrane).
• Acetylcholine is actively transported into its vesicles for
storage by the vesicle-associated transporter, VAT. This
process can be inhibited by another research drug,
vesamicol.
• Release of acetylcholine—Release of transmitter stores
from vesicles in the nerve ending requires the entry of
calcium through calcium channels and triggering of an
interaction between SNARE (soluble N-ethylmaleimide-
sensitive-factor attachment protein receptor) proteins.
• Termination of action of acetylcholine—The action of
acetylcholine in the synapse is normally terminated by
metabolism to acetate and choline by the enzyme
acetylcholinesterase in the synaptic cleft.
• Norepinephrine (NE) is the primary transmitter at the
sympathetic postganglionic neuron-effector cell synapses
in most tissues.
• Dopamine may be a vasodilator transmitter in renal blood
vessels, but norepinephrine is a vasoconstrictor of these
vessels.
• Synthesis and storage—After transport across the cell
membrane, tyrosine is hydroxylated by tyrosine hydroxylase
to DOPA , decarboxylated to dopamine, and hydroxylated to
norepinephrine.
• Tyrosine hydroxylase can be inhibited by metyrosine.
• Norepinephrine and dopamine are transported into vesicles by
the vesicular monoamine transporter (VMAT) and are stored
there.
• Monoamine oxidase (MAO) inactivates a portion of the
dopamine and norepinephrine in the cytoplasm. Therefore,
MAO inhibitors may increase the stores of these transmitters
.
• VMAT can be inhibited by reserpine, resulting in depletion of
transmitter stores.
• Release and termination of action—Dopamine and
norepinephrine are released from their nerve endings by
the same calcium-dependent mechanism responsible for
acetylcholine release.
• Lack receptors for botulinum.
• Termination occurs via diffusion and reuptake
(especially uptake-1, by the norepinephrine transporter,
NET, or the dopamine transporter, DAT) reduce their
concentration in the synaptic cleft and stop their action.
• Outside the cleft, these transmitters can be
metabolized—by MAO and catechol-O-
methyltransferase (COMT)—and the products of these
enzymatic reactions are excreted.
• Drugs that block norepinephrine synthesis (eg,
metyrosine) or catecholamine storage (eg, reserpine) or
release (eg, guanethidine) were used in treatment of
several diseases (eg, hypertension) because they block
sympathetic but not parasympathetic functions.
1. Cholinoceptors: subdivided into two types:
• Muscarinic receptors—
• Nicotinic receptors—
2. Adrenoceptors:
• Alpha receptors—
• Beta receptors—
3. Dopamine Receptors:
• These sites include the CNS centers; the ganglia; the
postganglionic nerve terminals; the effector cell
receptors; and the mechanisms responsible for
transmitter synthesis, storage, release, and termination of
action
• A. Local Integration: Mainly provided through
mechanism of negative feedback.
• This effect is mediated by α2 receptors located on the
presynaptic nerve membrane.
• B. Systemic Reflexes: System reflexes regulate blood
pressure, gastrointestinal motility, bladder tone, airway
smooth muscle, and other processes.
• The control of blood pressure—by the baroreceptor
neural reflex and the renin-angiotensin-aldosterone
hormonal response.
• C. Complex Organ Control: The Eye
• The pupil, is under reciprocal control by the SANS (via α
receptors on the pupillary dilator muscle) and the PANS
(via muscarinic receptors on the pupillary constrictor).
• The ciliary muscle, which controls accommodation, is
under primary control of muscarinic receptors innervated
by the PANS, with insignificant contributions from the
SANS.
Introduction to autonomic pharmacology
Introduction to autonomic pharmacology
Introduction to autonomic pharmacology
Introduction to autonomic pharmacology

Weitere ähnliche Inhalte

Was ist angesagt?

Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
coolboy101pk
 

Was ist angesagt? (20)

Neurotransmitters in CNS
Neurotransmitters in CNSNeurotransmitters in CNS
Neurotransmitters in CNS
 
cholinergic receptors
cholinergic receptorscholinergic receptors
cholinergic receptors
 
General and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptxGeneral and Local Anaesthetics drugs.pptx
General and Local Anaesthetics drugs.pptx
 
Seminar on histamine
Seminar on histamineSeminar on histamine
Seminar on histamine
 
Ganglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffiGanglionic stimulants and blockers suffi
Ganglionic stimulants and blockers suffi
 
Neurohumoral transmission in ans
Neurohumoral transmission  in  ansNeurohumoral transmission  in  ans
Neurohumoral transmission in ans
 
Serotonin pharmacology
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
 
L5: Adrenergic agonists; sympathomimetics
L5: Adrenergic agonists; sympathomimeticsL5: Adrenergic agonists; sympathomimetics
L5: Adrenergic agonists; sympathomimetics
 
Acetylcholine - A neurotransmitter
Acetylcholine - A neurotransmitterAcetylcholine - A neurotransmitter
Acetylcholine - A neurotransmitter
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017
 
Introduction to cns pharmacology
Introduction to cns pharmacologyIntroduction to cns pharmacology
Introduction to cns pharmacology
 
Neurotransmission
NeurotransmissionNeurotransmission
Neurotransmission
 
Autonomic system and Autonomic Pharmacology
Autonomic system and Autonomic PharmacologyAutonomic system and Autonomic Pharmacology
Autonomic system and Autonomic Pharmacology
 
Cholinergic antagonists
Cholinergic antagonistsCholinergic antagonists
Cholinergic antagonists
 
drugs acting on autonomic nervous system
drugs acting on autonomic nervous systemdrugs acting on autonomic nervous system
drugs acting on autonomic nervous system
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology
 
Histamine and antihistamin
Histamine and antihistaminHistamine and antihistamin
Histamine and antihistamin
 
Neurohumoral Transmission in CNS
Neurohumoral Transmission in CNSNeurohumoral Transmission in CNS
Neurohumoral Transmission in CNS
 
Introduction to Autonomic Nervous System Pharmacology
Introduction to Autonomic Nervous System PharmacologyIntroduction to Autonomic Nervous System Pharmacology
Introduction to Autonomic Nervous System Pharmacology
 

Ähnlich wie Introduction to autonomic pharmacology

autonomic drugs ANS Lec 1.pptx
autonomic drugs ANS Lec 1.pptxautonomic drugs ANS Lec 1.pptx
autonomic drugs ANS Lec 1.pptx
Aymanshahzad4
 

Ähnlich wie Introduction to autonomic pharmacology (20)

Clinical Pharmacology notes:Drugs acting on the autonomic nervous syste mby d...
Clinical Pharmacology notes:Drugs acting on the autonomic nervous syste mby d...Clinical Pharmacology notes:Drugs acting on the autonomic nervous syste mby d...
Clinical Pharmacology notes:Drugs acting on the autonomic nervous syste mby d...
 
Peripheral n.s.
Peripheral n.s.Peripheral n.s.
Peripheral n.s.
 
autonomic drugs ANS Lec 1.pptx
autonomic drugs ANS Lec 1.pptxautonomic drugs ANS Lec 1.pptx
autonomic drugs ANS Lec 1.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
Banin munir
Banin munirBanin munir
Banin munir
 
Cholinergics/ Parasymathomomitic
Cholinergics/ ParasymathomomiticCholinergics/ Parasymathomomitic
Cholinergics/ Parasymathomomitic
 
details on Nervous system, Cholinergic System (acetylcholine) and Drugs
details on Nervous  system, Cholinergic System (acetylcholine) and Drugsdetails on Nervous  system, Cholinergic System (acetylcholine) and Drugs
details on Nervous system, Cholinergic System (acetylcholine) and Drugs
 
Cholinergic drugs
Cholinergic drugsCholinergic drugs
Cholinergic drugs
 
BCM-Neurochemistry.pdf
BCM-Neurochemistry.pdfBCM-Neurochemistry.pdf
BCM-Neurochemistry.pdf
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Organization of ans
Organization of ansOrganization of ans
Organization of ans
 
Chapter 2 adrenergic agents by somashekhar m metri
Chapter 2 adrenergic agents by somashekhar m metriChapter 2 adrenergic agents by somashekhar m metri
Chapter 2 adrenergic agents by somashekhar m metri
 
Autonomic nervous system (ANS)2
Autonomic nervous system (ANS)2Autonomic nervous system (ANS)2
Autonomic nervous system (ANS)2
 
Autonomic Nervous System Pharmacology
Autonomic Nervous System PharmacologyAutonomic Nervous System Pharmacology
Autonomic Nervous System Pharmacology
 
ANS.pdf
ANS.pdfANS.pdf
ANS.pdf
 
Neurotramsitters and Neuromodulators SlideShare
 Neurotramsitters and Neuromodulators SlideShare  Neurotramsitters and Neuromodulators SlideShare
Neurotramsitters and Neuromodulators SlideShare
 
clinical pharmacology,clinical,injections,pharmacological,what is pharmacolog...
clinical pharmacology,clinical,injections,pharmacological,what is pharmacolog...clinical pharmacology,clinical,injections,pharmacological,what is pharmacolog...
clinical pharmacology,clinical,injections,pharmacological,what is pharmacolog...
 
Acetylcholine ppt
Acetylcholine pptAcetylcholine ppt
Acetylcholine ppt
 
The autonomic nervous system
The autonomic nervous systemThe autonomic nervous system
The autonomic nervous system
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 

Mehr von UsmanKhalid135

Mehr von UsmanKhalid135 (20)

Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Cholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugsCholinoceptor activating and cholinesterase-inhibiting drugs
Cholinoceptor activating and cholinesterase-inhibiting drugs
 
Cholinoceptor Blockers
Cholinoceptor BlockersCholinoceptor Blockers
Cholinoceptor Blockers
 
Adrenergic Receptor Blockers
Adrenergic Receptor BlockersAdrenergic Receptor Blockers
Adrenergic Receptor Blockers
 
Pharmacokinetics Drug Distribution
Pharmacokinetics Drug DistributionPharmacokinetics Drug Distribution
Pharmacokinetics Drug Distribution
 
Pharmacokinetics Drug Transportation
Pharmacokinetics  Drug TransportationPharmacokinetics  Drug Transportation
Pharmacokinetics Drug Transportation
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 
Introduction to Pharmacology
Introduction to PharmacologyIntroduction to Pharmacology
Introduction to Pharmacology
 
Drug Elimination
Drug EliminationDrug Elimination
Drug Elimination
 
Bioavailability
BioavailabilityBioavailability
Bioavailability
 
Opioid Analgesics
Opioid AnalgesicsOpioid Analgesics
Opioid Analgesics
 
Drugs in Parkinsonism
Drugs in ParkinsonismDrugs in Parkinsonism
Drugs in Parkinsonism
 
Anti Pscychotic Drugs
Anti Pscychotic DrugsAnti Pscychotic Drugs
Anti Pscychotic Drugs
 
Anti Depressive Drugs
Anti Depressive DrugsAnti Depressive Drugs
Anti Depressive Drugs
 
Drugs Used in Hypertension
Drugs Used in HypertensionDrugs Used in Hypertension
Drugs Used in Hypertension
 
Drugs used in Heart Failure
Drugs used in Heart FailureDrugs used in Heart Failure
Drugs used in Heart Failure
 
Drugs Used In Angina
Drugs Used In AnginaDrugs Used In Angina
Drugs Used In Angina
 
Antiarrhythmic drugs
Antiarrhythmic drugsAntiarrhythmic drugs
Antiarrhythmic drugs
 
Nsaids, Acetaminophen
Nsaids, AcetaminophenNsaids, Acetaminophen
Nsaids, Acetaminophen
 
Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
 

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 

Introduction to autonomic pharmacology

  • 2. The nervous system is divided into two anatomical divisions: 1. The central nervous system (CNS), which is composed of the brain and spinal cord, 2. The peripheral nervous system, which includes neurons located outside the brain and spinal cord that is, any nerves that enter or leave the CNS.
  • 3.
  • 4.
  • 5. The peripheral nervous system is subdivided into the 1. EFFERENT DIVISION, the neurons of which carry signals away from the brain and spinal cord to the peripheral tissues, 2. AFFERENT DIVISION, the neurons of which bring information from the periphery to the CNS.
  • 6.
  • 7. • The efferent portion of the peripheral nervous system is further divided into two major functional subdivisions, the somatic and the autonomic systems. • The SOMATIC efferent neurons are involved in the voluntary control of functions such as contraction of the skeletal muscles essential for locomotion. • On the other hand, the AUTONOMIC system regulates the everyday requirements of vital bodily functions without the conscious participation of the mind.
  • 8. • All neurons are distinct anatomic units, and no structural continuity exists between most neurons. • Communication between nerve cells and between nerve cells and effector organs occurs through the release of specific chemical signals, called neurotransmitters, from the nerve terminals. This release is triggered by the arrival of the action potential at the nerve ending, leading to depolarization. • The neurotransmitters rapidly diffuse across the synaptic cleft or space (synapse) between neurons and combine with specific receptors on the postsynaptic (target) cell.
  • 9. • An important traditional classification of autonomic nerves is based on the primary transmitter molecules—acetylcholine or norepinephrine—released from their terminals and varicosities. A large number of peripheral ANS fibers synthesize and release acetylcholine; they are cholinergic fibers; that is, they work by releasing acetylcholine.
  • 10. • Acetylcholine (ACh) is the primary transmitter in all autonomic ganglia and at the synapses between parasympathetic postganglionic neurons and their effector cells. • It is the transmitter at postganglionic sympathetic neurons to the thermoregulatory sweat glands. • It is also the primary transmitter at the somatic (voluntary) skeletal muscle neuromuscular junction.
  • 11. • 1. Synthesis and storage—Acetylcholine is synthesized in the nerve terminal by the enzyme choline acetyltransferase (ChAT) from acetyl-CoA (produced in mitochondria) and choline (transported across the cell membrane). • Acetylcholine is actively transported into its vesicles for storage by the vesicle-associated transporter, VAT. This process can be inhibited by another research drug, vesamicol.
  • 12. • Release of acetylcholine—Release of transmitter stores from vesicles in the nerve ending requires the entry of calcium through calcium channels and triggering of an interaction between SNARE (soluble N-ethylmaleimide- sensitive-factor attachment protein receptor) proteins.
  • 13. • Termination of action of acetylcholine—The action of acetylcholine in the synapse is normally terminated by metabolism to acetate and choline by the enzyme acetylcholinesterase in the synaptic cleft.
  • 14.
  • 15. • Norepinephrine (NE) is the primary transmitter at the sympathetic postganglionic neuron-effector cell synapses in most tissues. • Dopamine may be a vasodilator transmitter in renal blood vessels, but norepinephrine is a vasoconstrictor of these vessels.
  • 16. • Synthesis and storage—After transport across the cell membrane, tyrosine is hydroxylated by tyrosine hydroxylase to DOPA , decarboxylated to dopamine, and hydroxylated to norepinephrine. • Tyrosine hydroxylase can be inhibited by metyrosine. • Norepinephrine and dopamine are transported into vesicles by the vesicular monoamine transporter (VMAT) and are stored there. • Monoamine oxidase (MAO) inactivates a portion of the dopamine and norepinephrine in the cytoplasm. Therefore, MAO inhibitors may increase the stores of these transmitters . • VMAT can be inhibited by reserpine, resulting in depletion of transmitter stores.
  • 17.
  • 18. • Release and termination of action—Dopamine and norepinephrine are released from their nerve endings by the same calcium-dependent mechanism responsible for acetylcholine release. • Lack receptors for botulinum.
  • 19. • Termination occurs via diffusion and reuptake (especially uptake-1, by the norepinephrine transporter, NET, or the dopamine transporter, DAT) reduce their concentration in the synaptic cleft and stop their action. • Outside the cleft, these transmitters can be metabolized—by MAO and catechol-O- methyltransferase (COMT)—and the products of these enzymatic reactions are excreted.
  • 20. • Drugs that block norepinephrine synthesis (eg, metyrosine) or catecholamine storage (eg, reserpine) or release (eg, guanethidine) were used in treatment of several diseases (eg, hypertension) because they block sympathetic but not parasympathetic functions.
  • 21. 1. Cholinoceptors: subdivided into two types: • Muscarinic receptors— • Nicotinic receptors— 2. Adrenoceptors: • Alpha receptors— • Beta receptors— 3. Dopamine Receptors:
  • 22.
  • 23.
  • 24.
  • 25. • These sites include the CNS centers; the ganglia; the postganglionic nerve terminals; the effector cell receptors; and the mechanisms responsible for transmitter synthesis, storage, release, and termination of action
  • 26. • A. Local Integration: Mainly provided through mechanism of negative feedback. • This effect is mediated by α2 receptors located on the presynaptic nerve membrane. • B. Systemic Reflexes: System reflexes regulate blood pressure, gastrointestinal motility, bladder tone, airway smooth muscle, and other processes. • The control of blood pressure—by the baroreceptor neural reflex and the renin-angiotensin-aldosterone hormonal response.
  • 27. • C. Complex Organ Control: The Eye • The pupil, is under reciprocal control by the SANS (via α receptors on the pupillary dilator muscle) and the PANS (via muscarinic receptors on the pupillary constrictor). • The ciliary muscle, which controls accommodation, is under primary control of muscarinic receptors innervated by the PANS, with insignificant contributions from the SANS.